Verici Dx plc (LON:VRCI – Get Free Report) was down 7.6% during mid-day trading on Tuesday . The stock traded as low as GBX 0.20 and last traded at GBX 0.21. Approximately 724,487 shares were traded during mid-day trading, a decline of 56% from the average daily volume of 1,651,250 shares. The stock had previously closed at GBX 0.23.
Verici Dx Trading Up 11.1%
The stock has a market cap of £5.72 million, a PE ratio of -0.28 and a beta of 1.22. The company has a quick ratio of 8.49, a current ratio of 3.94 and a debt-to-equity ratio of 3.03. The stock’s fifty day moving average price is GBX 0.27 and its 200 day moving average price is GBX 0.40.
About Verici Dx
Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.
Recommended Stories
- Five stocks we like better than Verici Dx
- AeroVironment’s Record Backlog and Earnings Beat Fuel Recovery Case
- Corning Just Locked In a Massive Verizon Fiber Deal as AI Infrastructure Expands
- 3 Under-$20 Stocks Tied to the Future of U.S. Energy and Materials
- Uncle Sam’s Quantum Leap: Feds Fund a $300M Quantum Supercycle
Receive News & Ratings for Verici Dx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verici Dx and related companies with MarketBeat.com's FREE daily email newsletter.
